Lista de obras -

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

scientific article published on 26 December 2019

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

artículo científico publicado en 2018

BRAF mutation and thyroid cancer recurrence

artículo científico publicado en 2014

Characterization of the Immune Microenvironment in Hepatocellular Carcinoma (HCC).

artículo científico publicado en 2017

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors

scientific article published on 13 March 2019

Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer

artículo científico publicado en 2018

Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis

scientific article published on 27 February 2018

Duplex ultrasound imaging to detect limb stenosis or kinking of endovascular device ⬇️

artículo científico publicado el 16 de febrero de 2012

Histopathological and Immunophenotypic Features of Ipilimumab-Associated Colitis Compared to Ulcerative Colitis.

artículo científico publicado en 2018

Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes

artículo científico publicado en 2019

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.

artículo científico publicado en 2017

Ipilimumab-Induced Enteritis without Colitis: A New Challenge

artículo científico publicado en 2016

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

scientific article published on 31 October 2019

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma

scientific article published on 16 August 2019

Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes

artículo científico publicado en 2020

Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma

scientific article published on 22 March 2019

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.

artículo científico publicado en 2013

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.

artículo científico publicado en 2017

Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival

artículo científico publicado en 2015

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

artículo científico publicado en 2019

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

scientific article published on 31 October 2019

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

scientific article published on 01 May 2019

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

scientific article published on 01 September 2019

Reply to C. Bal et al and M. Xing.

artículo científico publicado en 2015

Successful Treatment of Neoplastic Fever with Oxybutynin

scientific article published on 01 December 2019

Successful Treatment of Scar Pain with Scrambler Therapy

artículo científico publicado en 2019

T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma

artículo científico publicado en 2018

Targeting neoantigens to augment antitumour immunity

artículo científico publicado en 2017

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

artículo científico publicado en 2017

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

artículo científico publicado en 2018

Tumor Mutational Burden and Response Rate to PD-1 Inhibition.

artículo científico publicado en 2017

Weakness and Myalgia in a Patient With Hepatocellular Carcinoma Undergoing Checkpoint Inhibitor Therapy

artículo científico publicado en 2019

pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer.

artículo científico publicado en 2016

Lista de obras de

A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer

Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas

BRAF mutation and thyroid cancer recurrence

Characterization of the Immune Microenvironment in Hepatocellular Carcinoma (HCC).

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors

Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer

Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis

Duplex ultrasound imaging to detect limb stenosis or kinking of endovascular device ⬇️

Histopathological and Immunophenotypic Features of Ipilimumab-Associated Colitis Compared to Ulcerative Colitis.

Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and Outcomes

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.

Ipilimumab-Induced Enteritis without Colitis: A New Challenge

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma

Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes

Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.

Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.

Oligometastatic Adenocarcinoma of the Lung: A Therapeutic Opportunity for Long-Term Survival

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

Reply to C. Bal et al and M. Xing.

Successful Treatment of Neoplastic Fever with Oxybutynin

Successful Treatment of Scar Pain with Scrambler Therapy

T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma

Targeting neoantigens to augment antitumour immunity

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.

Tumor Mutational Burden and Response Rate to PD-1 Inhibition.

Weakness and Myalgia in a Patient With Hepatocellular Carcinoma Undergoing Checkpoint Inhibitor Therapy

pAKT Expression and Response to Sorafenib in Differentiated Thyroid Cancer.